Business
A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High - Investor's Business Daily

What the report says
Amylyx stock skyrocketed Tuesday after its GLP-1 drug reduced hypoglycemia in patients who've undergone bariatric surgery.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Beyond the Beat: How Kenneth Mugabi Uses Music to Speak to SocietyNile Post
Roosevelt Africa Trail Links Uganda, U.S. East Africa in Push for Trade and InvestmentNile Post
Mutasingwa: BRICS offers Uganda new opportunities in trade, investment and technologyNile Post